T. Rowe Price Health Sciences Fund
Limited financial coverage for PRHSX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on the research, development, manufacturing, or distribution of offerings related to healthcare, medicine, or the broader life sciences. While the portfolio has the liberty to invest in companies of any market capitalization, most of its holdings are projected to be in large- and medium-sized corporations.
- IPO
- 1995
- HQ
- Baltimore, MD, US
Price Chart
- Market Cap
- $11.14B
- Div Yield
- 10.99%
- 52W High
- $95.70
- 52W Low
- $74.50
- 50D MA
- $82.07
- 200D MA
- $83.58
- Beta
- 0.66
- Avg Volume
- 0
Get TickerSpark's AI analysis on PRHSX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PRHSX coverage
Recent articles, reports, and earnings notes.
No research on PRHSX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PRHSX report →Similar companies
Peers in the same neighborhood.